Cardiovascular disease remains to be a leading cause of death in most industrialized countries. Therefore, finding ways to reduce the mortality of cardiovascular complications remains an important public health goal. Due to the aging of the populations of developed countries & a common occurrence of risk factors, it is increasingly probable that a patient may have both Cancer and Cardiovascular disease. In addition, cytotoxic agents especially anthracylines used to treat cancer affect the cardiovascular and renal system. From the current survey it has been observed that most of the people are...